Apocrine carcinoma of the male breast

Surgical Practice

Volumn 16, Issue 4, 2012, Pages 160-163

  Dag, Ahmet ^a   Serinsoz, Ebru ^a   Ocal, Koray ^a  

^a MERSIN UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPITHELIAL MEMBRANE ANTIGEN; ESTROGEN RECEPTOR; GROSS CYSTIC DISEASE FLUID PROTEIN 15; PACLITAXEL; PROGESTERONE RECEPTOR; PROTEIN P53; PROTEIN S 100; TUMOR MARKER; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; AGED; APOCRINE CARCINOMA; ARTICLE; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER PROGNOSIS; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DRUG RESPONSE; ECHOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; LARGE CORE NEEDLE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE HYPERPLASIA; MALE; MALE BREAST; MASTECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; TUMOR CELL; TUMOR LOCALIZATION; TUMOR VOLUME; WHOLE BODY SCINTISCANNING;

EID: 84867873913     PISSN: 17441625     EISSN: 17441633     Source Type: Journal    
DOI: 10.1111/j.1744-1633.2012.00619.x     Document Type: Article

References (11)

1. Takeuchi H, Tsuji K, Ueno H, Kano T, Maehara Y. Clinicopathological feature and long-term prognosis of apocrine carcinoma of the breast in Japanese women. Breast Cancer Res. Treat. 2004; 88: 49-54.
2. Tanaka K, Imoto S, Wada N, Sakemura N, Hasebe K. Invasive apocrine carcinoma of the breast: clinicopathologic features of 57 patients. Breast J. 2008; 14 (2): 164-168.
3. Abati AD, Kimmel M, Rosen PP. Apocrine mammary carcinoma. A clinicopathologic study of 72 cases. Am. J. Clin. Pathol. 1990; 94: 371-377.
4. Krompecher E. Zur histogene und morphologie der cystenmamma (maldie kystique reclus, cystadenoma schimmelbuscin, mastitis chronica cystic konig) des intrakanaliken kystadenomas und der kystadenokarzinome der brustdruse (hidrokystoma, kystoadenoma, hidrokystadenocarzinoma mammae). Beitr. Pathol. Anat. 1916; 62: 403-410. (In German.)
5. Mossler J, Barton T, Brinkhous A etal. Apocrine differentiation in human carcinoma. Cancer 1980; 46: 2463-2471.
6. Tavassoli FA, Norris HJ. Intraductal apocrine carcinoma: a clinicopathologic study of 37 cases. Mod. Pathol. 1994; 7: 813-818.
7. Kopans DB, Nguyen PL, Koerner FC etal. Mixed form, diffusely scattered calcifications in breast cancer with apocrine features. Radiology 1990; 177: 807-811.
8. Gilles R, Lesnik A, Guinebretiere JM etal. Apocrine carcinoma: clinical and mammographic features. Radiology 1994; 190: 495-497.
9. Eusebi V, Millis RR, Cattani MG etal. Apocrine carcinoma of the breast: a morphologic and immunocytochemical study. Am. J. Pathol. 1986; 123: 532-541.
10. Japaze H, Emina J, Diaz C, Schwam RJ etal. 'Pure' invasive apocrine carcinoma of the breast: a new clinicopathological entity? Breast 2005; 14 (1): 3-10.
11. Vranic S, Tawfik O, Palazzo J etal. EGFR and HER-2/neu expression in invasive apocrine carcinoma of the breast. Mod. Pathol. 2010; 23 (5): 644-653. Epub 2010 Mar 5.